User profiles for Paul Russo

Paul Russo MD

- Verified email at mskcc.org - Cited by 51551

Paul S. Russo

- Verified email at mse.gatech.edu - Cited by 7204

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

…, RJ Motzer, AA Hakimi, MH Voss, P Russo… - Nature …, 2019 - nature.com
Immune checkpoint inhibitor (ICI) treatments benefit some patients with metastatic cancers,
but predictive biomarkers are needed. Findings in selected cancer types suggest that tumor …

Phase transitions in the assembly of multivalent signalling proteins

…, JV Hollingsworth, DS King, SF Banani, PS Russo… - Nature, 2012 - nature.com
Cells are organized on length scales ranging from ångström to micrometres. However, the
mechanisms by which ångström-scale molecular properties are translated to micrometre-…

Guideline for management of the clinical T1 renal mass

…, JH Kaouk, RJ Leveillee, SF Matin, P Russo… - The Journal of …, 2009 - auajournals.org
DETECTION of clinical stage 1 (7.0 cm) renal masses has increased in frequency and is
now a common clinical scenario for the practicing urologist. 1–4 These tumors are very …

[PDF][PDF] Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

…, J Bacik, BA Murphy, P Russo… - Journal of …, 2002 - pfizerpro.com.s3.amazonaws.com
Purpose: To define outcome data and prognostic criteria for patients with metastatic renal
cell carcinoma (RCC) treated with interferon-alfa as initial systemic therapy. The data can be …

Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study

…, AJ Vickers, GV Raj, PT Scardino, P Russo - The lancet …, 2006 - thelancet.com
Background Chronic kidney disease is a graded and independent risk factor for substantial
comorbidity and death. We aimed to examine new onset of chronic kidney disease in …

Epidemiology of renal cell carcinoma

…, F Bray, J Coleman, JL Gore, M Sun, C Wood, P Russo - European urology, 2019 - Elsevier
Context Despite the improvement in renal cell carcinoma (RCC) diagnosis and management
observed during the last 2 decades, RCC remains one of the most lethal urological …

Partial nephrectomy versus radical nephrectomy in patients with small renal tumors—is there a difference in mortality and cardiovascular outcomes?

…, EB Elkin, AS Levey, TL Jang, P Russo - The Journal of …, 2009 - auajournals.org
Purpose : Compared with partial nephrectomy, radical nephrectomy increases the risk of
chronic kidney disease, which is a significant risk factor for cardiovascular events and death. …

ROOT—A C++ framework for petabyte data storage, statistical analysis and visualization

…, S Panacek, F Rademakers, P Russo… - Computer Physics …, 2009 - Elsevier
ROOT is an object-oriented C++ framework conceived in the high-energy physics (HEP)
community, designed for storing and analyzing petabytes of data in an efficient way. Any …

[PDF][PDF] Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma

…, LH Schwartz, V Reuter, P Russo… - Journal of clinical …, 2004 - scholar.archive.org
… Schwartz, Victor Reuter, Paul Russo, Stephanie Marion, and Madhu Mazumdar …
Motzer RJ, Russo P: Systemic therapy for renal cell carcinoma. J Urol 163:408-417, 2000 6 …

A postoperative prognostic nomogram for renal cell carcinoma

…, V REUTER, RJ MOTZER, J KATZ, P RUSSO - The Journal of …, 2001 - auajournals.org
Purpose : Few published studies have combined prognostic factors to predict the likelihood
of recurrence after surgery for renal cell carcinoma. We developed a nomogram for this …